Skip to content

A Pilot Study of the Effectiveness of Foot-Ankle and Walking Exercises in Patients With Diabetes Mellitus

A Pilot Study of Feasibility a for a Definitive Randomized Controlled Trial of Foot-Ankle Versus Walking Exercises in Patients With Diabetes Mellitus: Effects on Neuropathy, Stress, and Quality of Life

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251027005
Enrollment
108
Registered
2025-10-27
Start date
2024-07-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Diabetic Peripheral Neuropathy Diabetic Foot Diabetes Diabetes (DM) Diabetic Peripheral Neuropathy Stress Quality of life Fasting blood glucose Body mass index Blood pressure Ankle-brachial index Diabetes mellitus Exercise Waliking exercise Foot-ankle exercise Study Design

Interventions

Foot-ankle exercise group received usual care provided by the public health center and intervention via health education and leaflets about foot-ankle exercise. At the first meeting, participants lear
Foot-ankle exercise group,Walking exercise group,Control Group

Sponsors

Principal Investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 People with type 2 diabetes 2 Aged 20-70 years 3 Diagnosed with DM for at least 1 year 4 Can walk without assistance 5 Able to communicate well 6 Can read and write 7 Willing to be a respondent

Exclusion criteria

Exclusion criteria: 1 Has a history of leg amputation 2 Have a diagnosis of heart failure, kidney failure, pulmonary TB, and stroke 3 Patients with a history or under-treatment of mental disorders 4 DM patients with foot ulcers 5 DM patients with fractures or difficulty using the lower extremities

Design outcomes

Primary

MeasureTime frame
Recruitment Rate From first site-open to last enrolment. Participants enrolled per month per site and overall; eligibility and consent proportions,Retention baseline, 6 weeks (T1), 12 weeks (T2) Proportion with complete outcome data at T1 and T2 (per arm/overall),Adherence to Assigned Exercise 12 weeks Percentage of prescribed sessions achieved foot-ankle or walking min 150 min per week with no two consecutive non-exercise days; proportion meeting adherence threshold (min 70),Data Completeness T0, T1, T2 Proportion of non-missing values for exploratory outcomes,Adverse Events Baseline to 12 week Exercise-related adverse events/serious adverse events (number and percentage),Acceptability of the Intervention (Open-Ended Participant Feedback) 12 weeks Open-ended questions elicit participants messages/impressions, barriers, and difficulties during the intervention.

Secondary

MeasureTime frame
Diabetic peripeheral neuropathy (DPN) Baseline (before intervention/0 week), at 6-weeks and 12-weeks DPN measured by MNSI, Foot sensation will be measured using Semmes Weinstein Monofilament 10g, Foot vibration measurement using Tunning Fork 128Hz,Stress of People with Diabetes Mellitus Baseline (before intervention/0 week), at 6-weeks and 12-weeks Stress will be measured using the Indonesian version of the Problem Areas in Diabetes (PAID) questionnaire,Obstacles to Diabeter Related Quality of Life (DR-QoL) Baseline (before intervention/0 week), at 6-weeks and 12-weeks Obstacles to DR-QoL measured using 8 domains of the Indonesian version of the Diabetes Obstacles Questionnaire Short Version (DOQ-30) which we have previously tested for validity and reliability. ,Fasting Blood Glucose (FBG) of People with Diabetes Mellitus Baseline (before intervention/0 week), at 6-weeks and 12-weeks] FBG were measured using venous blood after the respondent fasted for at least 8 hours.,Blood Pressure of People with Diabetes Mellitus Baseline (before intervention/0 week), at 6-weeks and 12-weeks Blood pressure will be measured using a digital tensimeter, ,Body Mass Index Baseline (before intervention/0 week), at 6-weeks and 12-weeks Body weight was measured using digital scales, and height using height-measuring devices. BMI is calculated using the - Page 7 of 18 [DRAFT] -formula body weight (kg) divided by height2 (m2),Ankle-Brachial Index (ABI) Baseline (before intervention/0 week), at 6-weeks and 12-weeks ABI measurements carried out using continuous-wave Doppler ultrasound using SOPs prepared previously

Countries

Indonesia

Contacts

Public ContactSiti Fadlilah

Taipei Medical University

sitifadlilah@respati.ac.id085710844204

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026